Is Bismuth Subcitrate/Metronidazole/Tetracycline Still Hard to Find in 2026?

If you've been struggling to fill a prescription for Bismuth Subcitrate/Metronidazole/Tetracycline — the combination medication sold as Pylera — you've probably been wondering: is this drug actually in shortage, or is my pharmacy just out of stock?

Here's what we know as of 2026, and what you can do about it.

Current Shortage Status

As of early 2025, Bismuth Subcitrate/Metronidazole/Tetracycline was not officially listed on the FDA Drug Shortage Database. That means the FDA does not consider it to be in a formal nationwide shortage.

However, many patients continue to experience difficulty finding this medication at their local pharmacies. This gap between official shortage status and real-world availability is common with specialty drugs that have limited manufacturers.

The situation has improved since 2023, when Par Pharmaceutical launched the first generic version of Pylera. Before that, Allergan (now AbbVie) was the sole manufacturer, making the supply more vulnerable to disruptions.

Why Is Bismuth Subcitrate/Metronidazole/Tetracycline Still Hard to Find?

Even without a formal shortage, several factors continue to make this medication difficult to locate:

Limited Manufacturing Base

Only two companies currently produce this medication — AbbVie (brand-name Pylera) and Par Pharmaceutical (generic). With just two manufacturers, any production issue at either facility can create supply gaps across the country.

Niche Medication, Low Pharmacy Priority

Bismuth Subcitrate/Metronidazole/Tetracycline treats a specific condition (H. pylori infections) and isn't prescribed as frequently as common medications like blood pressure pills or Metformin. Many pharmacies don't keep it in regular stock, ordering it only when a prescription comes in.

Complex Manufacturing Process

The unique capsule-within-a-capsule design — containing three different active ingredients — makes production more complex than single-ingredient drugs. This can lead to longer manufacturing timelines and occasional production delays.

Supply Chain Variability

Drug distribution in the U.S. involves multiple layers — manufacturers, wholesalers, and pharmacies. Certain regions or pharmacy chains may have better access than others at any given time, creating a patchwork of availability.

How Much Does Bismuth Subcitrate/Metronidazole/Tetracycline Cost in 2026?

Cost is a significant factor for many patients. Here's what you can expect to pay:

• Brand-name Pylera (without insurance): $900 to $1,181 for a 10-day course of 120 capsules
• Generic version (without insurance): $305 to $500 at retail pharmacy prices
• Generic with discount coupon (GoodRx, SingleCare): As low as $187 for a 10-day course
• With insurance: Copays typically range from $10 to $75 depending on your plan and whether the generic is covered at a preferred tier

For a detailed breakdown of savings options, read our guide on how to save money on Bismuth Subcitrate/Metronidazole/Tetracycline.

Are There New Options for H. pylori Treatment?

The landscape of H. pylori treatment continues to evolve. In addition to Bismuth Subcitrate/Metronidazole/Tetracycline, several other FDA-approved and guideline-recommended options exist:

• Traditional bismuth quadruple therapy — the same drugs prescribed separately (Bismuth Subsalicylate + Metronidazole + Tetracycline + PPI)
• Talicia (Omeprazole/Amoxicillin/Rifabutin) — a newer combination approved in 2019
• Concomitant therapy — PPI + Amoxicillin + Clarithromycin + Metronidazole
• Vonoprazan-based regimens — Voquezna (Vonoprazan/Amoxicillin) or Voquezna Triple Pak with Clarithromycin, approved in 2023

Learn more in our article on alternatives to Bismuth Subcitrate/Metronidazole/Tetracycline.

How to Find Bismuth Subcitrate/Metronidazole/Tetracycline in Stock

If you need this medication now, here are actionable steps:

1. Use Medfinder to check which pharmacies near you have it in stock right now.
2. Ask for the generic version — it's the same drug at a fraction of the cost and may be more widely available.
3. Try independent pharmacies — they often have more flexible ordering channels than large chains.
4. Request a special order — most pharmacies can get it within 1-3 business days from their wholesaler.
5. Consider mail-order — mail-order pharmacies may have broader inventory access.

For a detailed walkthrough, read our full guide on how to find Bismuth Subcitrate/Metronidazole/Tetracycline in stock near you.

Final Thoughts

While Bismuth Subcitrate/Metronidazole/Tetracycline isn't in a formal FDA shortage, real-world availability remains inconsistent in 2026. The addition of a generic version in 2023 was a major improvement, and tools like Medfinder make it easier than ever to locate pharmacies with stock.

If you're currently dealing with an H. pylori infection and can't find this medication, don't delay treatment. Talk to your doctor about alternatives and use the resources above to find a pharmacy that can help you. Your health comes first.

For more information, explore our articles on what Bismuth Subcitrate/Metronidazole/Tetracycline is, side effects to watch for, and drug interactions to avoid.